Should We Leave Something There?

DOI QR Code

Chang Hoon Lee (Division of Cardiology, Department of Internal Medicine, Veterans Health Service Medical Center) ;
Weon Kim (Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University)

Ko YG, Ahn CM, Min PK, et al. Baseline characteristics of a retrospective patient cohort in the Korean vascular intervention society endovascular therapy in lower limb artery diseases (K-VIS ELLA) registry. Korean Circ J 2017;47:469-76.
Cha JJ, Lee JH, Ko YG, et al. Clinical outcomes of atherectomy plus drug-coated balloon versus drug-coated balloon alone in the treatment of femoropopliteal artery disease. Korean Circ J 2022;52:123-33.
Kim S. Improving the outcomes of complex lesions of the femoropopliteal artery using atherectomy and drug coated balloon. Korean Circ J 2022;52:134-5.
Park JI, Ko YG, Lee SJ, et al. Clinical outcomes after drug-coated balloon treatment in popliteal artery disease: K-POP registry 12-month results. Korean Circ J 2024;54:454-65.
Torsello G, Stavroulakis K, Brodmann M, et al. Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 2020;27:693-705.
Wu X, Peng Z, Qin J, Yang X, Lu X, Ye K. Outcomes of drug-coated balloon angioplasty for isolated chronic occlusion of the popliteal artery: a retrospective single-institution study. J Vasc Interv Radiol 2021;32:593-601.
Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions. J Endovasc Ther 2017;24:181-8.